Kiltearn Partners’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $26.2M | Sell |
365,068
-76,700
| -17% | -$5.91M | 7.05% | 3 |
|
|
2025
Q4 | $35.1M | Sell |
441,768
-88,400
| -17% | -$6.97M | 7.59% | 3 |
|
|
2025
Q3 | $40M | Buy |
530,168
+8,500
| +2% | +$583K | 8.01% | 2 |
|
|
2025
Q2 | $36M | Sell |
521,668
-31,500
| -6% | -$2.07M | 7.24% | 4 |
|
|
2025
Q1 | $37.5M | Sell |
553,168
-95,200
| -15% | -$5.7M | 7.14% | 3 |
|
|
2024
Q4 | $29.1M | Sell |
648,368
-68,500
| -10% | -$3.84M | 4.81% | 6 |
|
|
2024
Q3 | $45.1M | Sell |
716,868
-74,800
| -9% | -$4.36M | 6.13% | 3 |
|
|
2024
Q2 | $46.8M | Sell |
791,668
-69,500
| -8% | -$4.35M | 5.67% | 3 |
|
|
2024
Q1 | $68.5M | Sell |
861,168
-126,640
| -13% | -$9.67M | 6.33% | 3 |
|
|
2023
Q4 | $78M | Sell |
987,808
-20,660
| -2% | -$1.47M | 6% | 3 |
|
|
2023
Q3 | $70.4M | Buy |
1,008,468
+64,800
| +7% | +$4.59M | 5.56% | 3 |
|
|
2023
Q2 | $65.2M | Buy |
943,668
+68,300
| +8% | +$4.86M | 4.77% | 5 |
|
|
2023
Q1 | $65M | Buy |
875,368
+117,600
| +16% | +$9.86M | 4.7% | 6 |
|
|
2022
Q4 | $70.6M | Sell |
757,768
-357,211
| -32% | -$34.5M | 5.18% | 5 |
|
|
2022
Q3 | $106M | Sell |
1,114,979
-44,630
| -4% | -$4.42M | 6.16% | 3 |
|
|
2022
Q2 | $107M | Sell |
1,159,609
-102,900
| -8% | -$10M | 5.63% | 4 |
|
|
2022
Q1 | $128M | Sell |
1,262,509
-235,900
| -16% | -$24.8M | 5.5% | 4 |
|
|
2021
Q4 | $155M | Sell |
1,498,409
-63,800
| -4% | -$5.9M | 6.39% | 2 |
|
|
2021
Q3 | $133M | Sell |
1,562,209
-69,300
| -4% | -$5.8M | 5.48% | 4 |
|
|
2021
Q2 | $136M | Sell |
1,631,509
-15,400
| -0.9% | -$1.26M | 5.45% | 4 |
|
|
2021
Q1 | $124M | Buy |
1,646,909
+232,200
| +16% | +$16.9M | 4.73% | 6 |
|
|
2020
Q4 | $96.6M | Buy |
1,414,709
+27,200
| +2% | +$1.77M | 4.62% | 8 |
|
|
2020
Q3 | $81M | Buy |
1,387,509
+58,200
| +4% | +$3.62M | 4.93% | 6 |
|
|
2020
Q2 | $86.4M | Sell |
1,329,309
-13,400
| -1% | -$844K | 4.88% | 6 |
|
|
2020
Q1 | $79.7M | Sell |
1,342,709
-252,800
| -16% | -$16.9M | 5.29% | 8 |
|
|
2019
Q4 | $119M | Sell |
1,595,509
-74,700
| -4% | -$5.25M | 4.48% | 9 |
|
|
2019
Q3 | $104M | Sell |
1,670,209
-130,500
| -7% | -$7.73M | 3.77% | 12 |
|
|
2019
Q2 | $98.1M | Buy |
1,800,709
+30,300
| +2% | +$1.63M | 3.11% | 13 |
|
|
2019
Q1 | $95.5M | Sell |
1,770,409
-217,008
| -11% | -$13.4M | 2.71% | 17 |
|
|
2018
Q4 | $130M | Sell |
1,987,417
-1,165,378
| -37% | -$87M | 3.66% | 11 |
|
|
2018
Q3 | $248M | Sell |
3,152,795
-43,600
| -1% | -$3.12M | 5.72% | 4 |
|
|
2018
Q2 | $206M | Sell |
3,196,395
-75,900
| -2% | -$5M | 4.63% | 5 |
|
|
2018
Q1 | $205M | Buy |
3,272,295
+132,300
| +4% | +$9.49M | 4.99% | 6 |
|
|
2017
Q4 | $228M | Buy |
3,139,995
+1,074,795
| +52% | +$78.1M | 5.69% | 5 |
|
|
2017
Q3 | $168M | Buy |
2,065,200
+1,461,400
| +242% | +$116M | 4.91% | 9 |
|
|
2017
Q2 | $48.6M | Buy |
+603,800
| New | +$47.7M | 1.56% | 19 |
|
Other funds holding CVS
VCM
VPM
Kiltearn Partners's CVS Position: Q1 2026 in Review
Kiltearn Partners reduced its CVS Health (CVS) stake by 17% in Q1 2026, selling an estimated $5.91M and leaving 365,068 shares worth $26.2M. The position accounts for 7.05% of the portfolio, ranked #3.
Kiltearn Partners first reported a position in CVS in Q2 2017 and has held it in 36 quarters since. The position peaked at $248M in Q3 2018. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Kiltearn Partners held 365,068 shares of CVS Health worth $26.2M as of Q1 2026.
- Kiltearn Partners sold 76,700 CVS Health shares in Q1 2026, an estimated $5.91M.
- CVS Health made up 7.05% of Kiltearn Partners's portfolio in Q1 2026, its #3 holding.
- Kiltearn Partners first reported a position in CVS Health in Q2 2017 and has held it in 36 quarters since.
- Kiltearn Partners's CVS Health position peaked at $248M in Q3 2018.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Kiltearn Partners's 13F filing for Q1 2026, filed 14 May 2026.